You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康常衞清成為江蘇省腸癌篩查項目指定產品
格隆匯 05-29 10:07

格隆匯5月29日丨5月28日上午,江蘇省多靶點糞便FIT-DNA大腸癌篩查項目在江蘇省健康管理金陵論健期間正式啟動。

從左至右:中國健康促進基金會健康管理部主任吳非、諾輝健康董事長兼CEO朱葉青、江蘇省人民醫院管理中心主任張羣、解放軍總醫院第二醫學中心健康管理研究院主任曾強、江蘇省醫師協會副祕書長王躍、江蘇省醫師協會醫師健康管理與醫師健康保險專業委員會主任委員許津、鼓樓醫院健康管理中心主任周衞紅

江蘇省多靶點糞便FIT-DNA大腸癌篩查項目以張羣教授為項目負責人,聯合江蘇省內15家健康管理機構,以應用多靶點糞便FIT-DNA篩查技術為基礎,計劃覆蓋至少2萬例體檢高風險人羣。項目內容具體包括高危人羣科普篩查,待篩人羣的技術推薦,多靶點糞便FIT-DNA檢測服務以及陽性人羣后續導診以及全流程數據的跟蹤隨訪。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account